Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors in Treatment of Glioblastoma
Glioma is the most common primary intracranial tumor, and most patients present as glioblastoma, with high morbidity and mortality. The prognosis of patients with glioblastoma remains poor after surgical resection combined with standardized treatment of radiotherapy and chemotherapy. In recent years...
| Published in: | Zhongliu Fangzhi Yanjiu |
|---|---|
| Main Authors: | LI Yingying, LI Jinhu, LIU Xiaodong |
| Format: | Article |
| Language: | Chinese |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2022-05-01
|
| Subjects: | |
| Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.21.1069 |
Similar Items
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01)
by: JIA Xiaorong, et al.
Published: (2024-05-01)
A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
by: Melina Yerolatsite, et al.
Published: (2025-04-01)
by: Melina Yerolatsite, et al.
Published: (2025-04-01)
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01)
by: Antonio Omuro
Published: (2022-08-01)
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)
by: Patrizia Leone, et al.
Published: (2021-05-01)
Radiotherapy plus immune checkpoint inhibitor in prostate cancer
by: Tianjie Li, et al.
Published: (2023-07-01)
by: Tianjie Li, et al.
Published: (2023-07-01)
Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy
by: Kaixiao Zhou, et al.
Published: (2022-12-01)
by: Kaixiao Zhou, et al.
Published: (2022-12-01)
Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
by: Shaoping Shen, et al.
Published: (2020-08-01)
by: Shaoping Shen, et al.
Published: (2020-08-01)
Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
by: Hao Zhang, et al.
Published: (2024-06-01)
by: Hao Zhang, et al.
Published: (2024-06-01)
Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma
by: Kosuke Ueda, et al.
Published: (2024-03-01)
by: Kosuke Ueda, et al.
Published: (2024-03-01)
Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy
by: Yang Tang, et al.
Published: (2025-08-01)
by: Yang Tang, et al.
Published: (2025-08-01)
Assessment of the clinical effectiveness and safety of immune checkpoint inhibitors for glioblastoma: A systematic review
by: Nicholas Calvin, et al.
Published: (2023-12-01)
by: Nicholas Calvin, et al.
Published: (2023-12-01)
Advances in radiotherapy enhancing the efficacy of immune checkpoint inhibitors in malignant
by: Yao Liao, et al.
Published: (2025-07-01)
by: Yao Liao, et al.
Published: (2025-07-01)
Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma
by: Alexander H. Shannon, et al.
Published: (2023-07-01)
by: Alexander H. Shannon, et al.
Published: (2023-07-01)
Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)
by: Amina Ghouzlani, et al.
Published: (2021-07-01)
Incidences of pneumonitis associated with the combination of radiotherapy and immune checkpoint inhibitors in lung cancer: a systematic review and meta-analysis
by: Jing Li, et al.
Published: (2025-04-01)
by: Jing Li, et al.
Published: (2025-04-01)
Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape
by: Julio F. Inocencio, et al.
Published: (2024-09-01)
by: Julio F. Inocencio, et al.
Published: (2024-09-01)
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
by: Zhifei Gao, et al.
Published: (2023-02-01)
by: Zhifei Gao, et al.
Published: (2023-02-01)
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors
by: Jennifer K. Matsui, et al.
Published: (2022-09-01)
by: Jennifer K. Matsui, et al.
Published: (2022-09-01)
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
by: Kassidy M. Jungles, et al.
Published: (2022-10-01)
by: Kassidy M. Jungles, et al.
Published: (2022-10-01)
Radiotherapy combined with anti-CEACAM1 immunotherapy to induce survival advantage in glioma
by: Jinhu Li, et al.
Published: (2023-03-01)
by: Jinhu Li, et al.
Published: (2023-03-01)
Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer
by: Ziwei Wang, et al.
Published: (2025-05-01)
by: Ziwei Wang, et al.
Published: (2025-05-01)
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
by: Xiaotong Lu, et al.
Published: (2022-06-01)
by: Xiaotong Lu, et al.
Published: (2022-06-01)
Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade
by: Mengting Li, et al.
Published: (2025-07-01)
by: Mengting Li, et al.
Published: (2025-07-01)
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01)
by: David Spillane, et al.
Published: (2025-04-01)
The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors
by: Ruizhi Zhao, et al.
Published: (2024-03-01)
by: Ruizhi Zhao, et al.
Published: (2024-03-01)
Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model
by: JiaMin Huang, et al.
Published: (2024-12-01)
by: JiaMin Huang, et al.
Published: (2024-12-01)
Respiratory adverse effects in patients treated with immune checkpoint inhibitors in combination with radiotherapy: a systematic review and meta-analysis
by: Zhongjun Ma, et al.
Published: (2024-10-01)
by: Zhongjun Ma, et al.
Published: (2024-10-01)
Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)
by: Zhijun Chen, et al.
Published: (2025-08-01)
Hepatobiliary complications of immune checkpoint inhibitors in cancer
by: Donna Zhuang, et al.
Published: (2024-07-01)
by: Donna Zhuang, et al.
Published: (2024-07-01)
Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2017-09-01)
by: Shuang ZHANG, et al.
Published: (2017-09-01)
Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01)
by: Tietze Stefanie, et al.
Published: (2021-04-01)
Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
by: Kuniyasu Takagi, et al.
Published: (2021-10-01)
by: Kuniyasu Takagi, et al.
Published: (2021-10-01)
Research progress of immune checkpoint inhibitor related autoimmune hypophysitis
by: LI Jia-yi, XING Bing
Published: (2020-03-01)
by: LI Jia-yi, XING Bing
Published: (2020-03-01)
Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)
by: Lénia Silva, et al.
Published: (2024-12-01)
Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)
Immune checkpoint inhibitor-induced thyroiditis and its potential mechanisms
by: Xueqian Mao, et al.
Published: (2025-06-01)
by: Xueqian Mao, et al.
Published: (2025-06-01)
Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review
by: Tongzhen Xu, et al.
Published: (2022-11-01)
by: Tongzhen Xu, et al.
Published: (2022-11-01)
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022-05-01)
by: Mathilde Bausart, et al.
Published: (2022-05-01)
Progress of immune checkpoint inhibitors for the treatment of myelodysplastic syndrome
by: ZHANG Ruo-xi, HAN Bing
Published: (2021-08-01)
by: ZHANG Ruo-xi, HAN Bing
Published: (2021-08-01)
Similar Items
-
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma
by: JIA Xiaorong, et al.
Published: (2024-05-01) -
A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
by: Melina Yerolatsite, et al.
Published: (2025-04-01) -
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01) -
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01) -
Radiotherapy plus immune checkpoint inhibitor in prostate cancer
by: Tianjie Li, et al.
Published: (2023-07-01)
